TY  - GEN
AU  - Janku,Filip
AU  - Wheler,Jennifer J
AU  - Hong,David S
AU  - Kurzrock,Razelle
TI  - Bevacizumab-based treatment in colorectal cancer with a NRAS Q61K mutation
SN  - 1776-260X
PY  - 2014///0606
KW  - Adult
KW  - Antibodies, Monoclonal, Humanized
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Bevacizumab
KW  - Biomarkers, Tumor
KW  - genetics
KW  - Colorectal Neoplasms
KW  - drug therapy
KW  - GTP Phosphohydrolases
KW  - Humans
KW  - Male
KW  - Membrane Proteins
KW  - Middle Aged
KW  - Mutation
KW  - Treatment Outcome
N1  - Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1007/s11523-013-0266-9
ER  -